After a slow start, bioengineering products head for the market
Since its founding nearly a decade ago, the biotechnology industry has become expert at cloning genes, but it has not cloned many profits. Despite investments in research and development that have exceeded $2 billion, only a handful of marketable products have emerged from the laboratory. But 1984 may be the year when biotechnology begins to live up to its vaunted potential. A number of new products are working their way through the arduous testing process. Some of the most promising substances that researchers hope...
To continue reading:
or
Log-In
